Wells Fargo analyst Michael Turrin raised the firm’s price target on DocuSign to $50 from $48 and keeps an Underweight rating on the shares. DocuSign’s Q2 results were mixed, with softer billings being offset by margin upside, the analyst tells investors in a research note. The debate remains around if/when Intelligent Agreement Management can move the needle and/or growth can turn a corner, the analyst says.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener